Search

everythinglearnresearchcommunity

for

Search:↓

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Steroid cell tumors in the ovary are rare, can produce testosterone causing symptoms, and are mainly treated with surgery.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Hair loss may increase heart disease risk.

Hormonal differences affect male pattern baldness.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

PCOS is caused by both genetics and environmental factors like diet and obesity.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Mouflon rams mature gradually with changes in body, horns, and hormones linked to age and seasons, reaching full sexual maturity well after puberty.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

SHBG may be a useful early indicator and treatment target for PCOS.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Multiple treatments work best for hair loss.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.